PEPFAR ZIMBABWE

The United States President’s Emergency Plan for AIDS Relief (PEPFAR) has been implementing comprehensive HIV programs in Zimbabwe since 2006 through the United States Agency for International Development (USAID) and the Centers for Disease Control and Prevention (CDC) with the goal of realizing an AIDS-Free Generation.  The focus of the PEPFAR program is to achieve epidemic control, which is defined as the point at which new HIV infections and AIDS related deaths have decreased and new infections have fallen below the number of AIDS-related deaths. In alignment with this UNAIDS global goal, epidemic control can be achieved by ensuring that at least 90 percent of people living with HIV (PLHIV) know their HIV status; 90 percent of those who know their status are adherent to antiretroviral treatment (ART); and 90 percent of those on ART are virally suppressed and no longer spread the virus. The PEPFAR portfolio covers the entire spectrum of HIV prevention, care and treatment services and has contributed to a reduction in HIV incidence among 15-49 year olds (0.48% in 2017 from an estimated 0.85% in 2009). To reach the aforementioned targets, PEPFAR Zimbabwe has prioritized 40 districts, which represent at least 80% of the HIV burden nationally, to receive a comprehensive package of HIV services tailored by age, sex and risk.

The PEPFAR program continues to support the Ministry of Health and Child Care (MOHCC) to reach treatment saturation by the end of  2018. This will be achieved through a direct service delivery model focused in Harare/Chitungwiza, Determined Resilient Empowered AIDS-Free Mentored and Safe (DREAMS) and Aggressive Saturation districts to identify PLHIV through provider initiated testing and counseling (PITC), targeted outreach, defaulter tracing and adherence counseling, surge Human Resources for Health (HRH) capacity, and community index testing. In addition, PEPFAR will support a central package including procurement and distribution of antiretroviral (ARVs) drugs and viral load (VL) reagents.  Ultimately, the PEPFAR program will increase the number of people receiving  ARVs. The program will also continue to support voluntary medical male circumcision (VMMC), orphan and vulnerable children (OVC), and targeted high-impact prevention activities.

To align with the overall goal of achieving the UNAIDS 90-90-90 strategy, a Key Populations strategy to scale-up clinical services targeting female sex workers (FSW) and men who have sex with men (MSM) is being  supported. Direct service delivery activities that increase access and quality of services received both at the facility and community level are also being supported.  They include: human resources, community ART refill groups (CARGS), mobile outreach initiation units and viral load reagents to catalyze the national VL scale-up plan which is currently at 6% of ART patients nationwide.

PEPFAR Zimbabwe remains committed to attaining the 90-90-90 goals outlined by UNAIDS, and is supporting the implementation of the Treat All (Test and Start) strategy being  implemented with the leadership and largely with the manpower and infrastructure of the Ministry of Health and Child Care (MOHCC).

To achieve the UNAIDS targets for epidemic control, PEPFAR has set its targets even higher.  It will ensure that at least 95% of people living with HIV know their HIV status, 95% of those who know their status are adherent to antiretroviral treatment (ART), and 95% of those on ART are virally suppressed and no longer spread the virus by 2030.

PEPFAR Zimbabwe program

Contact Information

PEPFAR Coordinator’s Office
U.S Embassy

2 Lorraine Drive, Bluffhill
Harare, Zimbabwe
Tel:+263-867-701-1000

Email: trogerm@state.gov

  • Reaching 90-90-90 Targets and Beyond: The President’s Emergency Plan for AIDS Relief (PEPFAR) has been implementing comprehensive HIV programs in Zimbabwe since 2006 through the United States Agency for International Development (USAID) and the Centers for Disease Control and Prevention (CDC) with the goal of realizing an AIDS-Free Generation.  The focus of the PEPFAR program is to achieve epidemic control, which is defined as the point at which new HIV infections and AIDS related deaths have decreased and new infections have fallen below the number of AIDS-related deaths.
  • In alignment with the UNAIDS global goal, epidemic control can be achieved by ensuring that at least 90 percent of PLHIV know their HIV status; 90 percent of those who know their status are adherent to antiretroviral treatment (ART); and 90 percent of those on ART are virally suppressed and no longer spread the virus.
  • The PEPFAR portfolio covers the entire spectrum of HIV prevention, care and treatment services and has contributed to a reduction in HIV incidence among 15-49 year olds (0.48% in 2017 from an estimated 0.85% in 2009). To reach the aforementioned targets, PEPFAR Zimbabwe has prioritized 40 districts, which represent at least 80% of the HIV burden nationally, to receive a comprehensive package of HIV services tailored by age, sex and risk.
  • HIV Testing and Counseling: In 2016, PEPFAR reached over 1.9M individuals with HIV testing and counseling services (HTS) and expects to reach over 2.5M individuals in 2017 through revised strategies such as index testing (contact tracing), innovative interventions such as HIV self-testing to reach older men and young adults, and a short-term surge in human resources to increase provider initiated testing and counseling in facilities in 2017.
  • Voluntary Medical Male Circumcision: VMMC is the cornerstone of biomedical HIV prevention in Zimbabwe where an estimated one new HIV infection is averted with every eight male circumcisions. In 2016, the PEPFAR program reached 159,000 males ages 15-29 with VMMC services and has increased targets in 2017 to 306,140 to reach additional men.
  • Surveys: Zimbabwe was one of 3 countries to pioneer the Population-Based HIV Impact Assessment (ZIMPHIA), revealing a decrease in national HIV prevalence from 15.1% (2010) to 14.0% (2016) in 15-49 year olds, as well as, a 50% decrease in new cases of HIV from 0.85% in 2009 to 0.48% in 2016 among adults ages 15 to 64 years.
  • Treatment: The PEPFAR program has increased its procurement of antiretroviral medicines (ARVs) to support 215,000 patients (an increase of 22,000 patients from the previous year). New strategies promoted by PEPFAR and adopted by the MOHCC, such as “Treat All,” have enabled the program to immediately start people who test HIV positive on ART.
  • DREAMS: PEPFAR kicked off the innovative Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe (DREAMS) Initiative in six districts in Zimbabwe with the aim of reducing new HIV infections by 40% among adolescent girls and young women by the end of 2017. In Zimbabwe, HIV prevalence rates for young women are two to three times higher than those of young men and evidence shows young women are less likely to be vulnerable to HIV and gender-based violence when offered relevant, gender-sensitive HIV prevention information, skills, and services in an enabling environment.  Through DREAMS, PEPFAR has provided HIV prevention messages and information to over 385,000 adolescent girls and young women and is providing a core package of services including: HIV testing, pre- and post-exposure prophylaxis, gender-based violence services, educational subsidies, and household economic strengthening targeting parents and caregivers.
  • Communities: PEPFAR continues to expand and introduce a number of new direct-service delivery (DSD) differentiated models of care to increase access and quality of services received both at the facility and community level. PEPFAR is supporting the scale-up of Community Adolescent Treatment Support groups (CATS) and Community ART Refill Groups (CARGS).

https://www.pepfar.gov/countries/cop/c71522.htm

The United States President’s Emergency Plan for AIDS Relief (PEPFAR) will partner with the Health Journalists Association of Zimbabwe (HeJAZ) to launch the  PEPFAR HIV and AIDS Media Awards Competition. The awards will cover Photo, Print/ Online and Broadcast Journalism categories.  Entries are invited from members of HeJAZ and should be submitted to the PEPFAR Media Awards Adjudication Committee (PMAAC) at the Public Affairs Section of the U.S. Embassy, 7th Floor, Gold Bridge, Harare no later than October 27, 2017.

Rules of the Competition:

  1. The entries should have been published/broadcast between October 2016 and October 2017 by a recognized media house or agency or carried on line with a byline of the author;
  2. The themes of the entries to be submitted for the competition must be in the area of HIV and AIDS;
  3. Entries can be submitted by members of HEJAZ;
  4. Submissions will be reviewed by the PMAAC comprising members selected by HeJAZ, health experts from the U.S. Health Team, representatives from the National AIDS Council (NAC) and the AIDS and TB Unit –  Ministry of Health and Child Care (MOHCC) and the Voluntary Media Council of Zimbabwe;
  5. The decision of the PMAAC is final and the winners will be announced and receive their awards as part of the commemoration of World AIDS Day 2017 on December 1 at a venue to be advised;
  6. The overall winner will receive a prize and certificate. Runner ups will be selected from each of the three (3 categories of journalism) and awarded a prize and a certificate;
  7. The PMAAC reserves the right not to award a prize in any of the categories if the entries do not satisfactorily meet the competition requirements.  In such an event, PMAAC may award such an award to deserving entries that may score second or third place in the other categories;
  • Entries are invited from the following three (3) categories:
    • Print Journalism: submissions should have a minimum of 300  and maximum of 1000 words comprising features/articles published in different media such as newspapers, newsletters, magazines and the website;
    • Photo Journalism: a minimum of a single photo a pictorial of up to 10 photos and an album of up to 20 photos (published and captioned) should be submitted;
    • Broadcast (Television/Radio) Journalism:broadcast material for submission should have a minimum duration of 1 minute and a maximum of an hour.  All broadcast materials should be supported/accompanied by a transcript written in English.

Prospective entrants are invited to submit entries accompanied by proof of their nationality to the PMAAC at the Public Affairs Section of the U.S. Embassy, 7th Floor, Gold Bridge, Harare no later than October 27, 2017.  Submissions can also be made via email on: NyakwendeG@state.gov  Further information is  obtainable from the U.S. Embassy Website.

  • Since 2006, PEPFAR has provided over US$650 million to Zimbabwe, including US$95 million for each of the past three years (US$285 million total), for HIV and AIDS interventions as designed in our annual Country Operational Plan (COP).
  • In 2015, we increased our investment and commitment to a record $128 million dollars that we have programmed so far to fund:
    • Our overall COP: $95 million
    • Additional support (above and beyond the COP) for VMMC activities: $13 million
    • DREAMS activities: $20 million

Results/ Target

  • As a direct result of this continuous support, by the end of FY2015,434,131 people were on antiretroviral therapy and receiving related HIV services and care.
  • In Financial Year 2015, PEPFAR  succeeded in supporting:
    •  HIV testing and counseling for over 429,609 pregnant women; of these, 29 174 women were known to be HIV positive at entry
    • 156,215 voluntary medical male circumcisions to reduce incidences of HIV among men; and
    •  301,694 orphans, vulnerable children, and their caregivers in Zimbabwe by providing them with education, social protection, or economic strengthening support.

PEPFAR successes are the result of working in collaboration with the government of Zimbabwe to attain an AIDS-free generation and, as such, our interventions are well aligned to the Zimbabwe National Strategic Plan and The UNAIDS 90-90-90 Strategy.  As partners, we are privileged to have everything we need to tackle HIV and AIDS head on; we have the tools, the science, and most importantly, we share similar goals for epidemic control.

What does targeting or epidemic control mean?

The following is how we will succeed in getting 80% of the population living with HIV and AIDS on Antiretrovirals  by the end of 2017:

  • PEPFAR resources in Zimbabwe are focused on achieving the greatest impact in epidemic control in a short space of time.  Resources in Zimbabwe will target 541 sites 36 districts for increased scale-up and will focus efforts on populations in which the numbers of new infections and of people living with HIV are highest.
  • Efforts to sustain key care and treatment support to 53 high volume sites representing over 50% of those currently on ART in the remaining districts will continue.

What is PEPFAR  specifically supporting?

  • PEPFAR  continues to support the government of Zimbabwe in the goal of achieving an AIDS-free generation through the scale-up of combination HIV prevention, treatment, care and support efforts in areas where the burden of HIV prevalence and of people living with HIV are the highest.
  • Voluntary medical male circumcision and the prevention of mother-to-child transmission of HIV are two of the HIV prevention strategies that PEPFAR funds focus on.
  • PEPFAR supports interventions that strengthen the health delivery systems, such as the development and delivery of high quality pre- and in-service training of health personnel, including doctors and nurses, as well as the strengthening of the management of district-level health information systems.

Zimbabwe: Number of individuals who received testing and counseling services for HIV and received their test results during the past 12 months. Click here (PDF 260 KB) for detailed 2014 Annual Program Results.

An exciting, yet challenging phase in the HIV response.

We have a global shared vision – Fast tracking the response to reach epidemic control, including the achievement of the UNAIDS 90-90-90* treatment targets by 2020.

To achieve this vision, PEPFAR is focusing on the highest-burden locations and populations in the countries in which we work. For more information, Click here (PDF 2.1 MB).

PEPFAR’s Goal: An AIDS-Free Generation

Under the leadership of the U.S. Global AIDS Coordinator, PEPFAR is committed to greater accountability, transparency and impact to help achieve an AIDS-Free generation.

Accelerating Children’s HIV/AIDS Treatment (ACT) Initiative

Saving childrens’ lives by doubling the number of children living with HIV receiving Anti-Retretroviral Treatment across 10 Sub-Saharan African countries.

Highlights from the world’s largest HIV intervention program

Lifeline Newsletter: Volume 1

Highlights from the world’s largest HIV intervention program

Lifeline Newsletter: Volume 2

 

Highlights from the world’s largest HIV intervention program

Lifeline Newsletter: Volume 3

The HIV Treat All Toolkit – a resource with 10 tools – summarizes key lessons to optimize facility-based HIV care and treatment for all HIV positive patients. The toolkit was developed in collaboration with the Ministry of Health and Child Care and the Organization for Public Health Interventions and Development (OPHID) and aligned to current World Health Organization guidelines and service delivery standards. Each tool provides five key ‘tips for optimization’: action points to address common challenges facilities face in providing quality HIV care and treatment.

What is ‘Treat All’?

Treat All is a term which refers to new WHO 2015 HIV Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection which recommends to “treat all” people living with HIV, including children, adolescents, adults, pregnant and breastfeeding women, and people with coinfections.  These recommendations have been adopted by the Ministry of Health and Child Care in the 2016 Guidelines for Antiretroviral Therapy for the Prevention and Treatment of HIV in Zimbabwe.  The recommendation reads that, “All individuals with a confirmed HIV diagnosis are eligible for anti-retroviral therapy (ART), irrespective of WHO clinical stage and CD4 level.”

The toolkit is available here:

Highlights from the world’s largest HIV intervention program

Lifeline Newsletter: Volume 4

Highlights from the world’s largest HIV intervention program

Lifeline Newsletter: Volume 5